Show simple item record

dc.contributor.authorKapur, Nitin
dc.contributor.authorMasters, Ian B
dc.contributor.authorMorris, Peter S
dc.contributor.authorGalligan, John
dc.contributor.authorWare, Robert
dc.contributor.authorChang, Anne B
dc.date.accessioned2018-10-23T12:31:45Z
dc.date.available2018-10-23T12:31:45Z
dc.date.issued2012
dc.identifier.issn8755-6863
dc.identifier.doi10.1002/ppul.21518
dc.identifier.urihttp://hdl.handle.net/10072/172350
dc.description.abstractRationale: Exacerbations in non-cystic fibrosis (CF) bronchiectasis are associated with worsening lung functions and quality of life. A standardized definition of exacerbation could improve clinical care and research. Objective: To formulate a clinically useful definition of pulmonary exacerbation for pediatric non-CF bronchiectasis. Methods: A cohort of 69 children with non-CF bronchiectasis was prospectively followed for 900 child-months. The changes in clinical, systemic, and lung function parameters from 81 exacerbations were statistically evaluated using conditional logistic regression, receiver operating characteristic, sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) to formulate a definition of a pulmonary exacerbation. Formation of major and minor criteria was statistically based and models were developed. Measurements and Main Results: Wet cough and cough severity (score ≥2) over 72-hr were the best predictors of an exacerbation with area under the curve (AUC) of 0.85 (95% CI 0.79–0.92) and 0.84 (95% CI 0.77–0.91), respectively. Sputum color, chest pain, dyspnea, hemoptysis, and chest signs were significant though minor criteria. Inclusion of serum C-reactive protein, amyloid-A, and IL6 to the definition improved its specificity and PPV. Our final combined model consisted of one major with one investigatory criterion (PPV 91%, NPV 72%); two major criteria (PPV 79%, NPV 91%); or one major and two minor criteria (PPV 79%, NPV 94%). Conclusions: Pulmonary exacerbation in children with non-CF bronchiectasis can be validly predicted using a standardized assessment of clinical features, with additional systemic markers improving predictive values. This definition potentially facilitates earlier detection (leading to appropriate management) of exacerbations. Pediatr Pulmonol. 2012; 47:68–75. © 2010 Wiley Periodicals, Inc.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherJohn Wiley & Sons, Inc.
dc.relation.ispartofpagefrom68
dc.relation.ispartofpageto75
dc.relation.ispartofissue1
dc.relation.ispartofjournalPediatric Pulmonology
dc.relation.ispartofvolume47
dc.subject.fieldofresearchPaediatrics and Reproductive Medicine not elsewhere classified
dc.subject.fieldofresearchPaediatrics and Reproductive Medicine
dc.subject.fieldofresearchcode111499
dc.subject.fieldofresearchcode1114
dc.titleDefining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorWare, Robert


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record